Thomson Reuters IP & Science industry experts at CPhI 2016
The world’s most prominent pharma executives are set to gather at Fira de Barcelona Gran Via on the 4th-6th October for three days of collaboration, information dissemination, and discussions that will define the future of the industry. This year’s edition welcomes 37,000 expected attendees from over 150 countries and 2,500+ exhibitors.
At CPhI Worldwide there will be over 20 dedicated zones covering ingredients, APIs, excipients, contract services, packaging, biopharma, machinery and many more. It’s an unmissable opportunity for all the latest and most innovative advancements, thought leadership, and above all else, a platform to drive forward pharma business.
Running directly alongside the pharmaceutical ingredients halls are four other co-located brands, helping visitors quickly identify the right event for their business’s needs:
- ICSE is an outsourcing focussed event designed to connect the pharmaceutical community with contract providers from clinical trials, CROs, logistics providers, data management firms and CMOs, bringing the contract community together under one roof
- InnoPack connects buyers and specifiers from the packaging and pharmaceutical industries, showcasing all the newest innovations in pharma packaging
- P-MEC Europe features exhibitors from traditional large-scale capital equipment to companies focussed on instrumental analysis, measuring and testing technologies, materials testing, laboratory and quality control
- Finished Dose Formulation FDF will launch as a new, co-located event bringing together every aspect of the finished dosage supply chain, from Big Pharma and CMO to in/out-licensing and dossier specialists
Thomson Reuters IP & Science will be present at CPhl in order to help companies of all sizes, business models and geographies. We can assist companies to grow their product portfolios, find the right suppliers, hone in on acquisition targets or develop strategies to penetrate new markets.
Our host of industry experts can help companies develop strategies to bring their products to market faster, better anticipate compliance risks and stay ahead of their competition.
We are proud to host exclusive speaking sessions such as “The Changing Dynamics of Global API Manufacturing" at the Pre-Connect Congress on October 3, 2016, with industry expert Mike Chace-Ortiz, and “Insights on exclusive Portfolio selection and Partner Identification” on October 6, 2016, with Thomas Whiteoak.
We will be hosting an Open House for LatAm Industry Leaders on October 3, 2016. This panel and networking reception will offer a great opportunity to connect with industry leaders, peers and develop new business strategies.
In addition, Thomson Reuters is also a proud sponsor of the Global Generics and Biosimilars Award for API Supplier of the Year, to be presented on October 4, 2016.
So come join us and let us help you make a meaningful impact on your business! Learn more here.
For additional insights in preparing for CPhI, we recommend:
Getting the most out of CPhI - 10 Tips
Download a supplemental event guide brought to you in collaboration between CPhI and Thomson Reuters IP & Science. “Getting the most out of CPhI” offers tips, insights, and key considerations for generic finished dose or API companies aiming to identify new partners or projects at the world's largest annual pharma event.
Complimentary special report: "Market Landscape: Sourcing, Partnering, and Compliance In 2016."
Brought to you by CPhI, the global pharma platform, and Thomson Reuters IP & Science, the leading source of intelligent information for pharma professionals around the world, "Market Landscape: Sourcing, Partnering, and Compliance In 2016" explores manufacturing and distribution practices, generics finished dose trends, biosimilars strategies, API capabilities, business development and more.
Join Clarivate Analytics, formerly the IP & Science business of Thomson Reuters, at other upcoming industry events:
2016 GPhA Fall Technical Conference
Each year, more than 700 generic industry professionals attend this unique educational conference. Hear presentations from experts from the FDA, industry and academia as they address key regulatory and technical issues impacting the generic industry.